Inventor · disambiguated record
Maike Schmidt
Also filed as: SCHMIDT MAIKE
6 granted patents·11 pending applications·21 citations·filing 2006–2023
79Inventor score
Top patents by PatentIndex Score
17 records- 0191US11306144B2B7-H4 antibodies and methods of use thereofFIVE PRIME THERAPEUTICS INC·Filed 2018·Granted Apr 19, 2022·6 cites·45 claims
- 0290US11814431B2B7-H4 antibodies and methods of use thereofFIVE PRIME THERAPEUTICS INC·Filed 2020·Granted Nov 14, 2023·3 cites·48 claims
- 0381US2024043542A1B7-h4 antibodies and methods of use thereofFIVE PRIME THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0479US8398976B2Antibodies to EGFL7 and methods for their useYE WEILAN·Filed 2011·Granted Mar 19, 2013·4 cites·57 claims
- 0578US10364466B2Biological markers for identifying patients for treatment with VEGF antagonistsGENENTECH INC·Filed 2013·Granted Jul 30, 2019·8 cites·17 claims
- 0672US2023013293A1B7-h4 antibodies and methods of use thereofFIVE PRIME THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0762US2009297512A1Compositions and methods for modulating vascular developmentGENENTECH INC·Filed 2009·Application pending·0 cites
- 0857US2010203041A1Antibodies to egfl7 and methods for their useGENENTECH INC·Filed 2007·Application pending·0 cites
- 0956US2007031437A1Compositions and methods for modulating vascular developmentGENENTECH INC·Filed 2006·Application pending·0 cites
- 1054US2010029491A1Methods and compositions for diagnostic use for tumor treatmentSCHMIDT MAIKE·Filed 2009·Application pending·0 cites
- 1154US2013129735A1Antibodies to egfl7 and methods for their useGENENTECH INC·Filed 2013·Application pending·0 cites
- 1251US8993249B2Anti-neuropilin antibodies and methods of useGENENTECH INC·Filed 2013·Granted Mar 31, 2015·0 cites·8 claims
- 1347US8790646B2Compositions and methods for modulating vascular developmentFILVAROFF ELLEN·Filed 2010·Granted Jul 29, 2014·0 cites·18 claims
- 1447US2014302056A2Diagnostic methods and compositions for treatment of cancerSCHMIDT MAIKE·Filed 2013·Application pending·0 cites
- 1544US2024228578A1Cd80 extracellular domain fc fusion protein therapyFIVE PRIME THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1641US2011076271A1Diagnostic methods and compositions for treatment of cancerGENENTECH INC·Filed 2010·Application pending·0 cites
- 1739US2015056190A1Diagnostic methods and compositions for treatment of cancerGENENTECH INC·Filed 2013·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →